Sharma D K, Smith T K, Weller C T, Crossman A, Brimacombe J S, Ferguson M A
Division of Molecular Parasitology & Biological Chemistry, Department of Biochemistry, University of Dundee, Dundee DD1 4HN, Scotland.
Glycobiology. 1999 Apr;9(4):415-22. doi: 10.1093/glycob/9.4.415.
De-N-acetylation of N-acetylglucosaminyl-phosphatidylino-sitol (GlcNAc-PI) is the second step of glycosylphosphatidylino-sitol (GPI) membrane anchor biosynthesis in eukaryotes. This step is a prerequisite for the subsequent processing of glucosaminyl-phosphatidylinositol (GlcN-PI) that leads to mature GPI membrane anchor precursors, which are transferred to certain proteins in the endoplasmic reticulum. In this article, we used a direct de-N-acetylase assay, based on the release of [14C]acetate from synthetic GlcN[14C]Ac-PI and analogues thereof, and an indirect assay, based on the mannosylation of GlcNAc-PI analogues, to study the substrate specificities of the GlcNAc-PI de-N-acetylase activities of African trypanosomes and human (HeLa) cells. The HeLa enzyme was found to be more fastidious than the trypanosomal enzyme such that, unlike the trypanosomal enzyme, it was unable to act on a GlcNAc-PI analogue containing 2-O-octyl-d- myo -inositol or on the GlcNAc-PI diastereoisomer containing l- myo -inositol (GlcNAc-P(l)I). These results suggest thatselective inhibition of the trypanosomal de-N-acetylase may be possible and that this enzyme should be considered as a possible therapeutic target. The lack of strict stereospecificity of the trypanosomal de-N-acetylase for the d- myo -inositol component was also seen for the trypanosomal GPI alpha-manno-syltransferases when GlcNAc-P(l)I was added to the trypanosome cell-free system, but not when GlcN-P(l)I was used. In an attempt to rationalize these data, we modeled the structure and dynamics of d-GlcNAcalpha1-6d- myo -inositol-1-HPO4-( sn )-3-glycerol and its diastereoisomer d-GlcNAcalpha1-6l- myo -inositol-1-HPO4-( sn )-3-glycerol. These studies indicate that the latter compound visits two energy minima, one of which resembles the low-energy conformer of former compound. Thus, it is conceivable that the trypanosomal de-N-acetylase acts on GlcNAc-P(l)I when it occupies a GlcNAc-PI-likeconformation and that GlcN-P(l)I emerging from the de-N-acetylase may be channeled to the alpha-mannosyltransferases in this conformation.
N-乙酰葡糖胺基磷脂酰肌醇(GlcNAc-PI)的去N-乙酰化是真核生物中糖基磷脂酰肌醇(GPI)膜锚生物合成的第二步。这一步骤是后续加工葡糖胺基磷脂酰肌醇(GlcN-PI)以产生成熟GPI膜锚前体的前提条件,这些前体在内质网中转移至某些蛋白质上。在本文中,我们使用了一种直接去N-乙酰化酶测定法(基于从合成的GlcN[14C]Ac-PI及其类似物中释放[14C]乙酸盐)和一种间接测定法(基于GlcNAc-PI类似物的甘露糖基化),来研究非洲锥虫和人(HeLa)细胞中GlcNAc-PI去N-乙酰化酶活性的底物特异性。我们发现HeLa酶比锥虫酶更为挑剔,与锥虫酶不同,它无法作用于含有2-O-辛基-d-肌醇的GlcNAc-PI类似物或含有l-肌醇(GlcNAc-P(l)I)的GlcNAc-PI非对映异构体。这些结果表明,选择性抑制锥虫去N-乙酰化酶可能是可行的,并且该酶应被视为一个可能的治疗靶点。当将GlcNAc-P(l)I添加到锥虫无细胞系统中时,锥虫GPIα-甘露糖基转移酶对d-肌醇成分也表现出缺乏严格的立体特异性,但使用GlcN-P(l)I时则未观察到这种情况。为了合理解释这些数据,我们对d-GlcNAcα1-6d-肌醇-1-HPO4-(sn)-3-甘油及其非对映异构体d-GlcNAcα1-6l-肌醇-1-HPO4-(sn)-3-甘油的结构和动力学进行了建模。这些研究表明,后一种化合物存在两个能量最小值,其中一个类似于前一种化合物的低能量构象。因此,可以想象,锥虫去N-乙酰化酶在GlcNAc-P(l)I占据类似GlcNAc-PI的构象时对其起作用,并且从去N-乙酰化酶产生的GlcN-P(l)I可能以这种构象被导向α-甘露糖基转移酶。